本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

乌龙制药

11.51
+0.10000.88%
盘后11.510.00000.00%16:05 EDT
成交量:48.49万
成交额:559.08万
市值:5.31亿
市盈率:-3.89
高:11.75
开:11.49
低:11.20
收:11.41
数据加载中...
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

重要事件披露

Form 8-K - Current report
2024/02/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/18

重要事件披露

Form 8-K - Current report
2024/01/02

重要事件披露

Form 8-K - Current report
2023/12/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/28

SEC问询函

Form CORRESP - Correspondence
2023/11/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/16

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/13

SEC问询函

Form CORRESP - Correspondence
2023/09/12

重要事件披露

Form 8-K - Current report
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/10

重要事件披露

Form 8-K - Current report
2023/08/04

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/07/27

重要事件披露

Form 8-K - Current report